StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)

Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%

Tvardi Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Tvardi Therapeutics's pe ratio was 70.9× on Jan 31, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202270.9×−3.7
2021Dec 31, 202174.6×–

More Tvardi Therapeutics figures

See a number that looks wrong?